LuciMito 500 mg is an anticancer medicine used primarily in
the treatment of adrenal cortical carcinoma. It helps control abnormal growth
of cancer cells and supports long term disease management. This medicine is
prescribed under specialist supervision and requires careful monitoring.
Patients in the United Kingdom, United States, Australia, Singapore and
Philippines rely on this treatment as part of advanced oncology care. LuciMito
plays a key role in improving symptom control and slowing disease progression
when used as directed by healthcare professionals.
Active Ingredient
Mitotane is an adrenolytic agent that selectively affects the adrenal cortex.
It belongs to the class of antineoplastic medicines and works by reducing
hormone production and destroying cancerous adrenal cells. This targeted action
helps manage hormone related symptoms and tumor growth.
Uses of LuciMito 500 mg
• Treatment of adrenal cortical carcinoma
• Management of hormone overproduction conditions
• Relief from symptoms related to adrenal tumors
• Support for long term cancer control
How LuciMito 500 mg Works
Mitotane works by selectively damaging the adrenal cortex cells which produce
hormones. It reduces cortisol production and interferes with tumor cell
metabolism. This leads to decreased tumor growth and hormone secretion helping
control disease progression and associated symptoms.
How to Use LuciMito 500 mg
- Take
the tablet exactly as prescribed by your doctor
- Swallow
with water preferably with meals
- Do not
alter dosage without medical advice
Possible Side Effects
• Nausea and vomiting
• Dizziness
• Fatigue
• Loss of appetite
Precautions
• Regular monitoring of hormone levels is required
• Avoid use during pregnancy unless advised
• Inform doctor about liver conditions
Safety Information
Always take LuciMito under strict medical supervision. Regular follow ups and
lab tests are important to ensure safe and effective treatment.
Storage
• Store below 25°C
• Keep away from moisture
• Keep out of reach of children